|
AU2013206520A1
|
|
Methods of enhancing immune response using electroporation-assisted vaccination and boosting
|
|
AU2009205643A1
|
|
Variable current density single needle electroporation system and method
|
|
CA2686855A1
|
|
Device and method for single-needle in vivo electroporation
|
|
AU2007322075A1
|
|
Methods of enhancing immune response using electroporation-assisted vaccination and boosting
|
|
US2008058706A1
|
|
Modular electroporation device with disposable electrode and drug delivery components
|
|
CN101426550A
|
|
Method and device for treating microscopic residual tumors remaining in tissues following surgical resection
|
|
CA2635437A1
|
|
Device and method for single-needle in vivo electroporation
|
|
CA2631719A1
|
|
Variable volume electroporation chamber and methods therefore
|
|
AU2006200389A1
|
|
High efficiency transfection based on low electric field strength, long pulse length
|
|
US2006084938A1
|
|
Enhanced delivery of naked DNA to skin by non-invasive in vivo electroporation
|
|
MXPA05005786A
|
|
Large-scale electroporation plates, systems, and methods of use.
|
|
EP1487976A2
|
|
Minimizing metal toxicity during electroporation enhanced delivery of polynucleotides
|
|
US7171264B1
|
|
Intradermal delivery of active agents by needle-free injection and electroporation
|
|
CN1638780A
|
|
Methods for particle-assisted polynucleotide immunization using a pulsed electric field
|
|
US6972013B1
|
|
Enhanced delivery of naked DNA to skin by non-invasive in vivo electroporation
|
|
US6678556B1
|
|
Electrical field therapy with reduced histopathological change in muscle
|
|
US2002146831A1
|
|
High efficiency transfection based on low electric field strength, long pulse length
|
|
US6520950B1
|
|
Method of electroporation-enhanced delivery of active agents
|
|
WO0056395A1
|
|
Method and apparatus for reducing electroporation-mediated muscle reaction and pain response
|
|
US6678558B1
|
|
Method and apparatus for reducing electroporation-mediated muscle reaction and pain response
|
